Skip to content
★ Sign in to follow
HB

Hualan Biological Vaccine Inc. Stock: price and insider trades · China

华兰疫苗

CN·Mcap CN¥11.3BHealth Care

No insider purchase over the last 90 days. The latest, by 娄源成, was filed 14 Jul 2022.

Hualan Biological Vaccine Inc.: what insiders have been doing

We have very little insider data for Hualan Biological Vaccine Inc. so far: the most recent filing dates from 14 July 2022. With so few records, no pattern can be drawn yet. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Insider Decl.
1
Thresholds
n/a
Buy Volume
€7,183
1 ops. · all time
Sell Volume
n/a
n/a

Since the insiders bought

  • Filed 14 Jul 2022 · 1578 days ago · €7,183
    +0.0%
    Entry CN¥35.00 · Close at T+365 CN¥35.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 13,060 of 26,897 companies
52.2
score / 100
Value
35
Quality
70
FCF yld3.1%
Earn yld1.6%
EV/EBITDA35.1x
ROE3.6%
Gross mgn78%
Net mgn15%
Debt/EBITDA0.9x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥18.87
Analyst consensus
2 analysts
·
CN¥21.13Target CN¥25.57(+35%)CN¥30.00
Income statement
RevenueCN¥1.2B
Gross profitCN¥935.6M78% margin
EBITDACN¥331.4M28% margin
Net incomeCN¥182.9M16.7% margin
Valuation
PER (trailing)57.2x
P/Book2.1x
Beta0.58
Balance sheet & cash
Market capCN¥11.3B
Total debtCN¥300.2M
Free Cash FlowCN¥347.4M
Profitability & ownership
ROE3.6%
ROA1.2%
% insiders83.1%
% institutions0.6%
Last declaration on 14 July 2022
Declarations1 total
  • ▲
    监事Executives
    48,717 CNY15SZSE
    900 shares100.0% of flowA股XSHESZSE:173000005681552000
    Canonical exit: 12 Oct 2022 (T+90)

1 of 1 declaration

About Hualan Biological Vaccine Inc.

华兰疫苗 is a company focused on the research, development, and production of vaccines. It primarily operates in the Chinese market and concentrates on public health solutions.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations